Tuesday, May 20, 2008

Rx-to-OTC Switches Offer Golden Opportunity.

Loratadine Destruction OTC?
At a set encounter in April, FDA’s Nonprescription Drugs Advisory Administrative unit recommended that FDA approve the use of loratadine for OTC use in the tending of chronic hives in component to its earlier congratulations regarding seasonal allergies.
Considering a asking from Blue Living thing of California that all 3 second-generation antihistamines be moved from Rx to OTC unwellness, the citizens NGO had recommended last year that loratadine, fexofenadine (Allegra), and cetirizine (Zyrtec — Pfizer) be made available without a content to aliment seasonal allergies, but FDA has not yet acted on this assemblage.
“Loratadine’s switching to OTC will be a very interesting condition for pharmacists,” said Randy P.
This is a part of article Rx-to-OTC Switches Offer Golden Opportunity. Taken from "Generic Allegra" Information Blog

No comments: